Back to Newsroom
Back to Newsroom

RDInvesting Provides Investors with Free In-Depth Equity Reports on BONE, MLNX, TSS and VAR

Tuesday, 28 January 2014 09:00 AM

Topic:

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.

Bacterin International Holdings Inc. (NYSEMKT: BONE) shares declined 1.41 percent to close at $0.70 a share Friday. The stock traded between $0.63 and $0.70 on volume of 202,678 shares traded. Analysts at Noble Financial have recently downgraded the company’s rating to "sell" from "hold". Shares of Bacterin International have fallen approximately 50.0 percent in the past year.

Find out more about Bacterin International including full access to the free equity report at:     
www.RDInvesting.com/BONE

Mellanox Technologies, Ltd. (NASDAQ: MLNX) shares declined 7.89 percent to close at $39.20 a share Friday. The stock traded between $39.13 and $40.85 on volume of 1.04 million shares traded. Analysts at Barclays have recently downgraded the company’s rating to "underweight" from "equal weight". Shares of Mellanox Technologies have fallen approximately 20.0 percent in the past year.

Find out more about Mellanox Technologies including full access to the free equity report at:       
www.RDInvesting.com/MLNX

Total System Services, Inc. (NYSE: TSS) shares declined 2.89 percent to close at $30.96 a share Friday. The stock traded between $30.84 and $31.66 on volume of 1.67 million shares traded. Analysts at Goldman Sachs have recently upgraded the company’s rating to "neutral" from "sell". Shares of Total System Services have gained approximately 30.0 percent in the past year.

Find out more about Total System Services including full access to the free equity report at:       
www.RDInvesting.com/TSS

Varian Medical Systems, Inc. (NYSE: VAR) shares declined 2.05 percent to close at $81.80 a share Friday. The stock traded between $81.76 and $83.14 on volume of 1.20 million shares traded. Analysts at Cantor Fitzgerald have recently upgraded the company’s rating to "buy" from "hold". Shares of Varian Medical Systems have gained approximately 10.0 percent in the past year.

Find out more about Varian Medical Systems including full access to the free equity report at:     
www.RDInvesting.com/VAR

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:                
Research Driven Investing          
[email protected]

Topic:
Back to newsroom
Back to Newsroom
Share by: